Comments
Loading...
Compass Therapeutics (NASDAQ:CMPX) Stock, Earnings Estimates, EPS, And Revenue
Compass Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 20
EPS Estimate
$-0.090
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$850.00K
Analyze the earnings history of Compass Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Compass Therapeutics (CMPX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.08 | $-0.11 | 27.3 % |
| Q2 | 2024-08-12 | $-0.10 | $-0.10 | 0.00 % |
| Q1 | 2024-05-13 | $-0.08 | $-0.11 | 27.3 % |
| Q4 | 2024-03-21 | $-0.11 | $-0.09 | -22.2 % |
Compass Therapeutics (CMPX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?
Compass Therapeutics (CMPX) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Compass Therapeutics (NASDAQ:CMPX)?
The Actual EPS was $-0.08, which beat the estimate of $-0.11.
What were Compass Therapeutics’s (NASDAQ:CMPX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.